<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; OBJECTIVES: Diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> (DN) is the leading cause of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> and <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> in developing countries </plain></SENT>
<SENT sid="1" pm="."><plain>Early detection and risk reduction measures can prevent DN </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of the study was to determine the risk factors for the development of <z:hpo ids='HP_0000093'>proteinuria</z:hpo> over a period of 12 years of follow up in normoalbuminuric type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients attending a specialized centre </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Of the 2630 type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> subjects newly registered in 1996, 152 (M:F;92:60) normoalbuminuric subjects had baseline and subsequent measurements of anthropometric, haemodynamic and biochemical details spanning 12 years </plain></SENT>
<SENT sid="4" pm="."><plain>The subjects were divided into 2 groups based on the renal status during follow up visits </plain></SENT>
<SENT sid="5" pm="."><plain>Group 1 (non-progressors) had persistent normoalbuminuria and group 2 (progressors) had persistent <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Presence of other <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> during follow up and details on <z:chebi fb="0" ids="35526">antidiabetic</z:chebi> and <z:chebi fb="0" ids="35674">antihypertensive agents</z:chebi> were noted </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: During median follow up of 11 years in subjects with <z:mpath ids='MPATH_458'>normal</z:mpath> renal function at baseline, 44.1 per cent developed <z:hpo ids='HP_0000093'>proteinuria</z:hpo> at follow up </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> levels, HbA 1 c, systolic blood pressure (SBP), <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, and <z:chebi fb="20" ids="16199">urea</z:chebi> levels were significantly higher at baseline among progressors than non-progressors </plain></SENT>
<SENT sid="9" pm="."><plain>Progressors had a longer duration of <z:mp ids='MP_0002055'>diabetes</z:mp> and significant fall in estimated glomerular filtration rate (eGFR) levels at follow up </plain></SENT>
<SENT sid="10" pm="."><plain>In Cox's regression analysis, baseline age, duration of <z:mp ids='MP_0002055'>diabetes</z:mp>, baseline HbA 1 c and mean values of HbA 1 c, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, SBP and presence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> showed significant association with the development of macroalbuminuria </plain></SENT>
<SENT sid="11" pm="."><plain>INTERPRETATION &amp; CONCLUSIONS: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients with uncontrolled <z:mp ids='MP_0002055'>diabetes</z:mp> and increase in blood pressure are at high risk of developing <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Age, long duration of <z:mp ids='MP_0002055'>diabetes</z:mp>, elevated BP, poor glycaemic control and presence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> were significantly associated with the progression of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
</text></document>